These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9732885)

  • 1. Radiofrequency catheter ablation versus medical therapy for initial treatment of supraventricular tachycardia and its impact on quality of life and healthcare costs.
    Bathina MN; Mickelsen S; Brooks C; Jaramillo J; Hepton T; Kusumoto FM
    Am J Cardiol; 1998 Sep; 82(5):589-93. PubMed ID: 9732885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPACT OF RADIOFREQUENCY CATHETER ABLATION ON HEALTH-RELATED QUALITY OF LIFE ASSESSED BY THE SF-36 QUESTIONNAIRE IN PATIENTS WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA.
    Papiashvili G; Tabagari-Bregvadze N; Brugada J
    Georgian Med News; 2018 Feb; (Issue):54-57. PubMed ID: 29578423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of radiofrequency catheter ablation versus medical treatment for paroxysmal supraventricular tachycardia in Japan.
    Ikeda T; Sugi K; Enjoji Y; Kasao M; Abe R; Ninomiya K; Yabuki S; Yamaguchi T
    J Cardiol; 1994; 24(6):461-8. PubMed ID: 7823285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes on quality-of-life and health care costs in patients with supraventricular tachycardia (radiofrequency catheter ablation versus medical therapy).
    Goldberg AS; Bathina MN; Mickelsen S; Nawman R; West G; Kusumoto FM
    Am J Cardiol; 2002 May; 89(9):1120-3. PubMed ID: 11988206
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia.
    Cheng CH; Sanders GD; Hlatky MA; Heidenreich P; McDonald KM; Lee BK; Larson MS; Owens DK
    Ann Intern Med; 2000 Dec; 133(11):864-76. PubMed ID: 11103056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency catheter ablation of supraventricular tachycardia in children and adolescents : feasibility and cost-effectiveness in a low-income country.
    Vida VL; Calvimontes GS; Macs MO; Aparicio P; Barnoya J; Castañeda AR
    Pediatr Cardiol; 2006; 27(4):434-9. PubMed ID: 16830085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INFLUENCE OF CATHETER ABLATION OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA ON PATIENTS' ANXIETY.
    Papiashvili G; Tabagari-Bregvadze N; Brugada J
    Georgian Med News; 2018 Feb; (Issue):58-60. PubMed ID: 29578424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of radiofrequency ablation versus medical therapy on the quality-of-life and exercise capacity in patients with accessory pathway-mediated supraventricular tachycardia: a treatment comparison study.
    Lau CP; Tai YT; Lee PW
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):424-32. PubMed ID: 7770362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs or ablation for supraventricular tachycardia?
    Mann DE
    Hosp Pract (Off Ed); 1995 Mar; 30(3):9, 12. PubMed ID: 7883814
    [No Abstract]   [Full Text] [Related]  

  • 10. Simplified approach to radiofrequency catheter ablation of paroxysmal supraventricular tachycardia.
    Wang L; Li J; Yao R; Song S
    Croat Med J; 2004 Apr; 45(2):167-70. PubMed ID: 15103753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of ablation of ventricular tachycardia in ischaemic cardiomyopathy: limitations in the trial evidence base.
    Chen Y; Gomes M; Garcia JV; Hunter RJ; Chow AW; Dhinoja M; Schilling RJ; Lowe M; Lambiase PD
    Open Heart; 2020; 7(1):e001155. PubMed ID: 32076562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ablation therapy on the quality of life in children with supraventricular tachycardia.
    Szafran E; Baszko A; Bukowska-Posadzy A; Łaźniak A; Moszura T; Siwińska A; Walkowiak J; Bobkowski W
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2550-2559. PubMed ID: 28617528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
    Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
    Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alprazolam use improves psychological status and reduces hospitalization costs in patients with paroxysmal supraventricular tachycardia underwent radiofrequency catheter ablation].
    Zhu YJ; Liu ZY; Chen Y; Zheng P; Zhu JH; Tao QM; Zheng LR; Wang QQ; Shi MJ; Qiu YG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Oct; 35(10):919-22. PubMed ID: 18206039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of radiofrequency ablation on health-related quality of life in patients with paroxysmal supraventricular tachycardia compared with a norm population one year after treatment.
    Walfridsson U; Walfridsson H; Arestedt K; Strömberg A
    Heart Lung; 2011; 40(5):405-11. PubMed ID: 21419492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness of radiofrequency catheter ablation in the treatment of symptomatic supraventricular tachyarrhythmias.
    Kertes PJ; Kalman JM; Tonkin AM
    Aust N Z J Med; 1993 Aug; 23(4):433-6. PubMed ID: 8240167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.
    Coyle K; Coyle D; Nault I; Parkash R; Healey JS; Gray CJ; Gardner MJ; Sterns LD; Essebag V; Hruczkowski T; Blier L; Wells GA; Tang ASL; Stevenson WG; Sapp JL
    JACC Clin Electrophysiol; 2018 May; 4(5):660-668. PubMed ID: 29798795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of supraventricular tachyarrhythmias: drugs or ablation?].
    Chimienti M; Barbieri S
    G Ital Cardiol; 1996 Feb; 26(2):213-26. PubMed ID: 8666179
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation.
    Reynolds MR; Zimetbaum P; Josephson ME; Ellis E; Danilov T; Cohen DJ
    Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):362-9. PubMed ID: 19808491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of treatment of supraventricular arrhythmias related to an accessory atrioventricular pathway: comparison of catheter ablation, surgical division and medical treatment.
    Weerasooriya HR; Murdock CJ; Harris AH; Davis MJ
    Aust N Z J Med; 1994 Apr; 24(2):161-7. PubMed ID: 8042944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.